• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    0.84 Down 0.00(0.38%) 4:02PM EDT
    Prev Close:0.84
    Open:0.85
    Bid:0.84 x 5700
    Ask:0.84 x 500
    1y Target Est:1.25
    Beta:-0.106963
    Earnings Date:Jul 28 - Aug 1 (Est.)
    Day's Range:0.81 - 0.85
    52wk Range:0.75 - 2.50
    Volume:342,775
    Avg Vol (3m):598,611
    Market Cap:129.81M
    P/E (ttm):N/A
    EPS (ttm):-0.16
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 0.38%129.81M
    LLYDown 0.70%79.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.08
    Quarterly EPS Est (Jun-16) :-0.02
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback